AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.
This table compares AdvanSource Biomaterials Corpration and Apyx Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|AdvanSource Biomaterials Corpration||14.15%||-175.54%||17.35%|
This table compares AdvanSource Biomaterials Corpration and Apyx Medical’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|AdvanSource Biomaterials Corpration||$3.35 million||0.96||$330,000.00||N/A||N/A|
|Apyx Medical||$16.69 million||14.25||$64.01 million||($0.29)||-24.17|
Apyx Medical has higher revenue and earnings than AdvanSource Biomaterials Corpration.
This is a summary of current recommendations and price targets for AdvanSource Biomaterials Corpration and Apyx Medical, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|AdvanSource Biomaterials Corpration||0||0||0||0||N/A|
Apyx Medical has a consensus target price of $8.00, suggesting a potential upside of 14.12%. Given Apyx Medical’s higher possible upside, analysts plainly believe Apyx Medical is more favorable than AdvanSource Biomaterials Corpration.
Institutional & Insider Ownership
50.9% of Apyx Medical shares are held by institutional investors. 7.8% of AdvanSource Biomaterials Corpration shares are held by company insiders. Comparatively, 6.0% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility & Risk
AdvanSource Biomaterials Corpration has a beta of -2.39, indicating that its stock price is 339% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 0.09, indicating that its stock price is 91% less volatile than the S&P 500.
Apyx Medical beats AdvanSource Biomaterials Corpration on 9 of the 12 factors compared between the two stocks.
About AdvanSource Biomaterials Corpration
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
About Apyx Medical
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Receive News & Ratings for AdvanSource Biomaterials Corpration Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSource Biomaterials Corpration and related companies with MarketBeat.com's FREE daily email newsletter.